Friday, August 02, 2019 12:34:12 AM
The Optune OS60 quoted by Novocure for treatment is 13%, and has been for years.
Whether you think there is something artificial or unreproducible about it e.g. open label bias, widespread censoring, is of course up to you.
The 'high compliance' subgroup stats for 3, 4, 5 years are the ones that are real baloney, and amount to nothing more than blatant misrepresentation. These were only 'produced' in the last 9 months or so, probably in response to the developing DCVax-L data.
These are the ones that could really mislead potential patients.
It's really clever marketing (the more you use it the better you will do), but also cynical and unethical, imo.
Whether you think there is something artificial or unreproducible about it e.g. open label bias, widespread censoring, is of course up to you.
The 'high compliance' subgroup stats for 3, 4, 5 years are the ones that are real baloney, and amount to nothing more than blatant misrepresentation. These were only 'produced' in the last 9 months or so, probably in response to the developing DCVax-L data.
These are the ones that could really mislead potential patients.
It's really clever marketing (the more you use it the better you will do), but also cynical and unethical, imo.
Recent NWBO News
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/26/2025 05:15:34 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
